Robert Rapaport, MD Email Robert Rapaport
-
- Position
- PROFESSOR | Pediatrics, Endocrinology and Diabetes
-
- Specialties
- Pediatrics
- Pediatric Endocrinology
-
- Languages
- English
- Spanish
-
- Hospital Affiliation
- The Mount Sinai Hospital
Robert Rapaport is Professor of Pediatrics and the Chief of the Division of Pediatric Endocrinology and Diabetes at the Icahn School of Medicine at Mount Sinai and at the Kravis Children’s Hospital at Mount Sinai. He is also the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes. Dr. Rapaport received his medical degree from State University of New York - Downstate Medical Center, training in Pediatrics at Schneider's Children's Hospital (Long Island Jewish Hospital - Hillside Medical Center) and his fellowship training in Pediatric Endocrinology at St. Christopher's Hospital for Children, Philadelphia and New York Hospital-Cornell Medical Center, New York. He has published numerous articles and chapters including chapters in major Pediatric (Nelson) and Pediatric Endocrinology (Sperling, Lifshitz and Pescovitz) textbooks. Dr. Rapaport’s current research interests include growth and growth hormone in children born SGA, neonatal thyroid disease, growth hormone-immune interactions, aspects of childhood diabetes and pubertal disorders.
Certifications
Pediatric Endocrinology
American Board of Pediatrics
Clinical Focus
- Autoimmune Hypothyroidism
- CHARGE Syndrome
- Children Born Small For Gestational Age
- Congenital Adrenal Hyperplasia
- Congenital Hyperinsulinism
- Congenital Hypothyroidism
- Delayed Puberty
- Graves Disease
- Growth Failure
- Growth Hormone Deficiency
- Hypergonadotropic Hypogonadism
- Hyperparathyroidism
- Hypogonadotropic Hypogonadism
- Hypoparathyroidism
- Idiopathic Short Stature
- Kleinfelter Syndrome
- Medication-Induced Diabetes
- Neonatal Graves Disease
- Neurofibromatosis
- Obesity
- Overgrowth
- Polycystic Ovary Syndrome
- Prader-Willi Syndrome
- Precocious Puberty
- Rickets
- Russell-Silver Syndrome
- Turner Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
Education
MD, S.U.N.Y., Health Science Center
Residency, Pediatrics
Long Island Jewish Medical Center
Fellowship, Pediatric Endocrinology
St. Christopher's Hosp. for Child.
Fellowship, Pediatric Endocrinology
New York Hospital Cornell University Med Ctr
Languages
English, Spanish
Kolevson A, Bush L, Wang A, Halpern D, Frank Y, Grodberg D, Rapaport R, Tavassoli T, Chaplin W, Soorya L, Buxbaum J. Erratum: A Pilot Controlled Trial of Insulin-Like Growth-Factor-1 in Children with Phelan-McDermid Syndrome. . Mol Autism. 2016; 2(6): 31.
Counts D, Silverman L, Rajicic N, Geffner M, Newfield R, Thornton P, Carakushansky M, Escobar O, Rapaport R, Levitsky L, Rotenstein D, Hey-Hadavi J, Wajnrajch M. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing. . Horm Res Paediatr 2015;.
Shapiro S, Klein G, Klein M, Wallach E, Fen Y, Godbold J, Rapaport R. SHOX Gene Varians: Growth Hormone/Insulin-Like Growth Factor-1 Status and Response to Growth Hormone Treatment. . Horm Res Paedatri. 2015; 83: 26-35.
Regelmann M, Graber E, Chia D, Rapaport R. Thyroid. In D.K. Stevenson, Neonatology: Clinical Practice and Procedures . McGraw-Hill Professional 2015;: 673-688.
Zeve D, Regelmann M, Holzman I, Rapaport R. Small at Birth, but How Small? Definition of Small for Gestational Age. . 2016;.
Goldis M, Waldman L, Marginean O, Kotlus Rosenberg H, Rapaport R. Thyroid Imaging in Infants. . Pediatric Endocrinolog; Endo and Metabolism Clinics of N. America. 2016 June;.
Romero CJ, Mehta L, Rapaport R. Genetic Techniques in the Evaluation of Short Stature. . Pediatric Endocrinolog; Endo and Metabolism Clinics of N. America 2016 June;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rapaport during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Novo Nordisk
- Sandoz
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.